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Abstract

Author Manuscript

The DSM-5 Self-rated Level 1 Cross-Cutting Symptom Measure was developed to aid in clinical
decision-making for clients seeking psychiatric services and to facilitate empirical investigation of
the dimensional nature of mental health issues. Preliminary evidence supports its utility with
clinical samples. However, the brief, yet comprehensive structure of the DSM-5 Level 1 measure
may benefit a high-risk population that is less likely to seek treatment. College students have high
rates of hazardous substance use and co-occurring mental health symptoms, yet rarely seek
treatment. Therefore, the current study evaluated the psychometric properties (i.e., construct and
criterion-related validity) of the DSM-5 Level 1 measure with a large, diverse sample of nontreatment-seeking college/university students. Data from 7,217 college students recruited from ten
universities in ten different states across the U.S. evidenced psychometric validation of the DSM-5
Level 1 measure. Specifically, we found acceptable internal consistency across multi-item DSM-5
domains and moderate to strong correlations among domains (internal validity). Further, several
DSM-5 domains were positively associated with longer, validated measures of same mental health
construct and had similar strengths of associations with substance use outcomes compared to
longer measures of the same construct (convergent validity). Finally, all DSM-5 domains were
negatively associated with self-esteem and positively associated with other theoretically relevant
constructs, such as posttraumatic stress (criterion-related validity). Taken together, the DSM-5
Level 1 measure appears to be a viable tool for evaluating psychopathology in college students.
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Several opportunities for clinical application and empirical investigation of the DSM-5 Level 1
measure are discussed.

Keywords
mental health; college students; substance use; psychometrics

Introduction

Author Manuscript

A primary goal for the recent edition of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-5; American Psychiatric Association [APA], 2013a) was to address the
high comorbidity and overlapping symptoms across mental health disorders (Clark & Kuhl,
2014). The DSM-5 Self-rated Level 1 Cross-Cutting Symptom Measure (hereinafter referred
to as DSM-5 level 1 measure; APA, 2013b) was developed in an effort to facilitate additional
empirical investigation of the dimensional nature of mental health issues. Broadly, the
DSM-5 level 1 measure is a brief, yet comprehensive assessment of mental health symptoms
that are commonly endorsed among clients seeking treatment, regardless of their primary
presenting concern (Narrow & Kuhl, 2011). Specifically, the DSM-5 level 1 measure
comprises 23 self-rated symptoms that capture 13 mental health domains: depression, anger,
mania, anxiety, somatic distress, suicidal ideation, psychosis, sleep disturbance, memory,
repetitive thoughts and behaviors, dissociation, personality functioning, and substance use.
Respondents indicate how much (or how often) they have been bothered by each symptom
in the prior two weeks using a five-point response scale (none, not at all to severe, nearly
every day). A score of 2 or higher in most domains, except substance use (score of 1 or
higher) is suggestive of clinically-relevant mental health problems (Narrow et al., 2013).

Author Manuscript
Author Manuscript

Preliminary evidence for the psychometric properties of the DSM-5 level 1 measure is
encouraging but insufficient. During the DSM-5 field trials, test-retest reliability estimates
ranged from good to excellent for all mental health domains, except mania among clients
recruited from seven treatment facilities across the United States (Narrow et al., 2013).
However, Bastiaens and Galus (2017) found high rates of false positives among a sample of
clients residing in a correctional community center, resulting in poor sensitivity and poor
positive predictive power. Though, sensitivity of the anxiety and psychosis domains and
negative predictive power (i.e., a negative screen) of the mania, anxiety, and psychosis
domains were good when they used the lowest domain thresholds. The researchers
concluded that the DSM-5 level 1 measure would benefit as a screener to rule out but not
necessarily identify mental health issues. Although these findings are notable, the
psychometric analyses are limited and restricted to only clinical samples (i.e., no prior
research has evaluated the psychometric properties of the DSM-5 level 1 measure in a
nonclinical sample). Additional psychometric validation in nonclinical samples is needed to
determine its wider applicability.
The DSM-5 level 1 measure may be particularly useful for the college/university student
population given the high prevalence of substance abuse, and increasing rates of mental
health issues. More specifically, 66.7% of college students in the U.S. endorse past-month
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alcohol use, 20.0% endorse past-month marijuana use, and roughly 30% endorse being
diagnosed or treated by a professional for a mental health disorder (predominately
depression and anxiety) within the past 12 months (American College Health Association,
2017). Similar to clinical populations, college students tend to endorse symptoms that span
several mental health disorders. Therefore, and in line with the purpose of the DSM-5 level 1
measure, examining the breadth of potential mental health issues can facilitate the
development of at-risk student profiles, and inform how best to address and tailor treatment
interventions.

Author Manuscript

The goal of the present study was to evaluate the psychometric properties (i.e., construct and
criterion-related validity) of the DSM-5 level 1 measure in a large, diverse sample of nontreatment-seeking college/university students at 4-year institutions from ten U.S. states
(Alaska, Colorado, Idaho, Mississippi, Missouri, Nebraska, New Mexico, Virginia,
Washington, and Wyoming). First, we assessed internal validity of the DSM-5 level 1
measure by examining the reliability of multiple-item mental health domains and
intercorrelations of mental health domains. Second, we assessed convergent validity by
examining the relation between mental health domains and longer, validated measures of the
same mental health construct. Next, we assessed criterion-related validity by evaluating the
association between mental health domains and theoretically-related measures of
psychopathology. Finally, we also compared correlations between the domains and past 30day substance use outcomes to correlations between established measures of the same
construct and past 30-day substance use outcomes in order determine if the DSM-5 level 1
measure can be a viable brief measure used to assess relationships between mental health
and substance use among college students.

Author Manuscript

Method
Participants and Procedures

Author Manuscript

Participants were college students recruited to participate in an online survey from
Psychology Department Participant Pools at ten universities across ten U.S. states. To ensure
that data collection was standardized at each site, all data were collected using the same
software (i.e., Qualtrics). To minimize burden on participants, we utilized a planned missing
data design, also known as matrix sampling (Graham, Taylor, Olchowski, & Cumsille,
2006). Specifically, each participant received and completed a battery of core measures that
focused on substance use (i.e., alcohol and marijuana) and the DSM-5 level 1 measure. After
completing the core measures, each participant received a random sample of 10 measures
from a larger pool (19 total measures) that assessed mental health (e.g., depression, anxiety,
stress, self-esteem, suicide, posttraumatic stress), physical health (i.e. sleep quality, sexual
experiences, eating habits), and personality (i.e., impulsivity-like traits, Big Five personality
traits, antisocial behavior, and temperament) constructs. Although 7,307 students were
recruited across sites, only data from students that completed the DSM-5 level 1 measure (n
= 7,217) were included in the final analyses. The majority of the analytic sample was White
(73.80%), female (70.54%), and reported a mean age of 20.85 (Median = 19.00; SD = 4.74)
years. Specific demographic information on our full sample as well as each data collection
site is shown in Supplemental Table 1. Participants received research participation credit for
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completing the study. This protocol was approved by the institutional review boards at each
participating university.
Non-DSM Level 1 Measures
Based on our missing-data-by-design procedure, at least 3,746 (51.91%) of participants
completed each randomized measure unless otherwise noted.

Author Manuscript

Depression, anxiety, and stress.—Past week depression, anxiety, and stress were
assessed using the 21-item Depression Anxiety Stress Scales (DASS-21; Lovibond &
Lovibond, 1995) measured on a 4-point response scale (0 = did not apply to me at all to 3 =
applied to me very much, or most of the time). We summed items to create a total score for
the three domains covered by the measure: depression (7 items; M = 3.42; SD = 4.48; α = .
92), anxiety (7 items; M = 3.15; SD = 3.86; α = .86), and stress (7 items; M = 4.18; SD =
4.24; α = .88).
Fear of Negative Evaluation.—Fear of negative evaluation was assessed using the 12item Brief Fear of Negative Evaluation Scale (BFNES; Leary, 1983), measured on a 5-point
response scale (1 = not at all characteristic of me to 5 = extremely characteristic of me).
Items were summed (M = 33.88; SD = 9.92; α = .89).
Social Interaction Anxiety.—Social interaction anxiety was assessed using the 20-item
Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998), measured on a 5-point
response scale (0 = not at all characteristic or true of me to 4 = extremely characteristic or
true of me). Items were summed (M = 26.24; SD = 15.81; α = .94).

Author Manuscript

Posttraumatic stress disorder.—Past month posttraumatic stress disorder (PTSD)
symptoms was assessed using the 20-item PTSD Checklist for DSM-5 (PCL-5; Blevins,
Weathers, Davis, Witte, & Domino, 2015), measured on a 5-point response scale (0 = not at
all to 4 = extremely). Items were summed (M = 16.00; SD = 16.67; α = .96).
Insomnia.—Past 2-week insomnia problems was assessed using the 7-item Insomnia
Severity Index (ISI; Bastien, Vallières, & Morin, 2001), measured on a 5-point response
scale (0 = not at all to 4 = extremely). The seven items assess severity of difficulties falling
asleep, staying asleep, sleep quality and its impact on daily functioning. We summed items
to create a total score of insomnia (M = 7.86; SD = 5.75; α = .88).

Author Manuscript

Suicidality.—Suicidality was assessed with three independent questions adapted from the
World Mental Health Composite International Diagnostic Interview (CIDI; Kessler & Üstün,
2004). The three questions focused on suicidal thought (“Did you think about killing
yourself?”), planning a suicide (“Did you make a plan to kill yourself?”), and suicide
attempts (“Did you make a suicide attempt or try to kill yourself?”). Participants reported
whether they did or did not (0 = no, 1 = yes) experience suicidal thoughts (16.01% endorsed
yes), plan to kill themselves (3.85% endorsed yes), and attempt suicide (1.89% endorsed
yes) in the past 12 months.
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Self-esteem.—Self-esteem was assessed using the 10-item Rosenberg Self-Esteem Scale
(Rosenberg, 1965), measured on a 5-point response scale (0 = strongly agree to 4 = strongly
disagree). We reverse-coded and summed items to create a total score with higher scores
indicating higher positive self-esteem (M = 20.27; SD = 5.86; α = .90).

Author Manuscript

Alcohol use.—Alcohol use was broken down into several indicators: an indicator of past
30-day frequency of alcohol use, an indicator of typical quantity, and an indicator of binge
drinking frequency (i.e., past 30-day frequency of drinking 4+/5+ standard drinks in for
women/men in a period of two hours or less). Typical quantity was measured with a
modified version of the Daily Drinking Questionnaire (Collins, Parks, & Marlatt, 1985).
Participants indicated how much they drink during a typical week in the past 30 days using a
7-day grid from Monday to Sunday. We summed number of standard drinks consumed on
each day of the typical drinking week (i.e., “weekly drinks”). Only participants that reported
at least one alcohol use day in the previous month (n = 5,001) completed the binge drinking
frequency and typical quantity questions.
Alcohol-related problems.—Past 30-day alcohol-related problems were assessed using
the 24-item Brief-Young Adult Alcohol Consequences Questionnaire (Kahler, Strong, &
Read, 2005). Each item was scored dichotomously (0 = no, 1 = yes) and we summed all
items to create an alcohol-related problem composite score reflective of the number of
distinct problems experienced in the past 30 days (α = .91). Only participants that reported
at least one alcohol use day in the previous month (n = 5,001) completed the measure.

Author Manuscript

Alcohol misuse.—Alcohol misuse was assessed using a modified version of the 10-item
Alcohol Use Disorder Identification Test (AUDIT; Saunders, Aasland, Babor, de la Fuente,
& Grant, 1993). The difference between the AUDIT and the modified version is that the
response options for items 1–3 were modified and the wording for item 3 reflects the U.S.
gender-specific definition of heavy episodic drinking (i.e., frequency of drinking 4+/5+
standard drinks in for women/men in a drinking period). We summed items to create a total
score for the two primary domains covered by the measure: alcohol consumption (3 items;
M = 5.71; SD = 3.60; α = .82) and alcohol-related problems (7 items; M = 2.42; SD = 3.55;
α = .78). Only participants that reported consuming alcohol at least once in their lifetime (n
= 6,366) completed the measure.

Author Manuscript

Marijuana use.—Marijuana use was broken down into several indicators: an indicator of
past 30-day marijuana use, an indicator of typical frequency of use, and an indicator of
typical quantity. Typical marijuana use frequency and quantity was assessed using the
Marijuana Use Grid (Author et al., 2018). Specifically, each day of the week was broken
down into 6 4-hour blocks of time (12a-4a, 4a-8a, 8a-12p, etc.), and participants were asked
to report at which times they used marijuana during a “typical week” in the past 30 days as
well as the quantity of grams consumed during that time block. We calculated typical
frequency of marijuana use by summing the total number of time blocks for which they
reported using during the typical week (ranges: 0–42). We calculated typical quantity of
marijuana use by summing the total number of grams consumed across time blocks during
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the typical week. Only participants that reported at least one marijuana use day in the
previous month (n = 2,175) completed the marijuana use frequency and quantity questions.
Marijuana-related problems.—Past 30-day marijuana-related problems were assessed
using the 21-item Brief Marijuana Consequences Questionnaire (Simons, Dvorak, Merrill, &
Read, 2012). Each item was scored dichotomously (0 = no, 1 = yes) and we summed all
items to create a marijuana-related problems composite score reflective of the number of
distinct problems experienced in the past 30 days (α = .89). Only participants that reported
at least one marijuana use day in the previous month (n = 2,175) completed the measure.

Author Manuscript

Marijuana misuse.—Marijuana misuse was assessed using the 8-item Cannabis Use
Disorders Identification Test-Revised (CUDIT-R; Adamson et al., 2010). We summed items
to create a total score with higher scores indicating higher marijuana misuse (M = 5.57; SD
= 5.82; α = .84). Only participants that reported consuming marijuana at least once in their
lifetime (n = 4,018) completed the measure.
Statistical Analyses

Author Manuscript

To test for internal validity, we examined the reliability of test scores from domains that had
multiple items and correlations between domains. To test for convergent validity (i.e.,
evidence of a relationship between the test scores and other scores from measures of the
same or similar construct), we examined the correlations between five specific domains and
other measures purported to assess the same (or similar) construct: 1) the depression domain
with the DASS-21 depression subscale; 2) the anxiety domain with the DASS-21 anxiety
subscale and two forms of social anxiety (fear of negative evaluation and social interaction
anxiety); 3) the suicidal ideation domain and three forms of suicidality (i.e., thoughts,
planning, and attempt); 4) the sleep disturbance domain with insomnia, and 5) the substance
use domain with reports on the AUDIT, CUDIT-R, and past 30-day alcohol and marijuana
use/problems. To test for criterion-related validity (i.e., the relationship between the test’s
scores with other theoretically relevant constructs), we examined the correlations between
the 13 domains and all mental health constructs mentioned in the measures section that were
not the exact same construct (e.g., correlation between depression and PTSD symptoms).

Author Manuscript

Furthermore, we compared correlations between these domains and past 30-day substance
use outcomes to correlations between established measures of the same construct and past
30-day substance use outcomes in order determine if the DSM-5 level 1 measure can be a
viable brief measure used to assess relationships between mental health and substance use.
Since we utilized a missing-data-by-design procedure, missing data are considered missing
completely at random or MCAR (Enders, 2010), which allows us to use Full Information
Maximum Likelihood in Mplus 7.4 to handle missing data (i.e., allows us to use all available
information in determining parameter estimates) (Muthén & Muthén, 1998–2017). Given
our large sample size (i.e., statistical power), significant associations were determined by a
99% bias-corrected standardized bootstrapped confidence interval (based on 10,000
bootstrapped samples) that does not contain zero and we place emphasis on the strength of
the associations.
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Results
Internal Validity and Descriptive Statistics
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Of the 13 domains assessed by the DSM-5 level 1 measure, eight had multiple items and
each of these domains had acceptable to good internal consistency (Loewenthal, 2001)
within this college student population: depression (2 items; M = 2.00; SD = 2.01; α = .82),
anger (1 item; M = .99; SD = 1.05), mania (2 items; M = 1.52; SD = 1.74; α = .63), anxiety
(3 items; M = 2.90; SD = 2.96; α = .84), somatic distress (2 items; M = 1.21; SD = 1.76; α
= .70), suicidal ideation (1 item; M = 0.28; SD = 0.74), psychosis (2 items; M = 0.29; SD = .
96; α = .80), sleep disturbance (1 item; M = .89; SD = 1.18), memory (1 item; M = .46; SD
= .87), repetitive thoughts and behaviors (2 items; M = .79; SD = 1.52; α = .75), dissociation
(1 item; M = .44; SD = .89), personality functioning (2 items; M = 1.48; SD = 1.98; α = .
81), and substance use (3 items; M = 1.06; SD = 1.81; α = .61). As expected, all domains
were significantly positively associated with each other and the majority of these magnitudes
were in the moderate (.30 < rs < .50) to strong range (r > .50).

Author Manuscript

Beyond examining mean rates and correlations among domains, we also calculated
prevalence rates (i.e., percentages) of participants who met the threshold for
psychopathology symptom criteria. Within the total sample and averaged across items, the
prevalence of potential symptom presentation for the domains are as follows: anxiety
(27.89%), depression (27.87%), anger (27.54%), sleep disturbance (25.47%), mania
(21.91%), personality functioning (20.07%), somatic distress (17.11%), memory (12.09%),
dissociation (11.70%), repetitive thoughts and behaviors (10.95%), suicidal ideation
(7.46%), and psychosis (4.00%). For substance use, we present the rates by specific
substance: alcohol use (32.06%), tobacco (15.53%), and other drug use (14.68%). Specific
percentage rates for each item in our full sample (and across data collection sites) is shown
in Supplemental Table 2. Specific percentage rates for each item across racial/ethnic
identities are shown in Supplemental Table 3. We also compared our sample to a community
sample obtained by Hurst and Kavanagh (2017). By and large, our sample demonstrated
lower rates on most mental health domains except for slightly higher prevalence of tobacco
use and prescription drug misuse (see Supplemental Table 2).
Convergent and Criterion-related Validity

Author Manuscript

Correlations between domains of the DSM-5 level 1 measure and mental health constructs
are summarized in Table 1. Across all domain specific correlations, all correlations were
significantly positive and the majority of these magnitudes were in the moderate to strong
range: 1) depression domain with the DASS-21 depression subscale (r = .67); 2) sleep
disturbance domain with insomnia (r = .66); 3) anxiety domain with fear of negative
evaluation (r = .42), social interaction anxiety (r = .48), and the DASS-21 anxiety subscale (r
= .58); 4) suicidal ideation domain with past year suicidality thoughts (r = .48), planning (r
= .39), and attempt (r = .23); 5) substance use domain with reports on the AUDIT
(consumption, r = .45; problems, r = .45), CUDIT-R (r = .37), and past 30-day alcohol/
marijuana use indicators and related problems (rs = .19-.41). With regards to criterionrelated validity, all domains of the DSM-5 level 1 measure were significantly positively
associated with each poor mental health construct (only exception was alcohol consumption
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assessed by the AUDIT; only four significant associations). The majority of these
magnitudes ranged from moderate-to-strong (see Table 1).

Author Manuscript

Correlations between health constructs and past 30-day substance use outcomes are
summarized in Table 2. Excluding the substance use domain of the DSM-5 level 1 measure,
there were relatively few significant associations between mental health constructs and both
alcohol and marijuana use indicators and all significant correlations were weak. In contrast,
almost all correlations between mental health constructs and alcohol/marijuana-related
problems were significant and had modest associations (correlations ranged from .15 to .31).
In comparing the associations between the five specific domains and other measures
assessing the same (or similar) construct on substance use outcomes, the correlations were
largely similar in strength (e.g., the correlation between the depression domain and
marijuana-related problems was .21 and the correlation between DASS-21 depression and
marijuana-related problems was .21). Other correlation comparisons were similar in strength
(i.e., .10 or less in magnitude difference).

Discussion

Author Manuscript

Broadly, the present study sought to test the utility of the DSM-5 level 1 measure in
assessing psychopathology among college students through a systematic testing of internal,
convergent, and criterion-related validity. Overall, the measure performed admirably. All
multi-item subscales of the DSM-5 level 1 measure demonstrated at least acceptable internal
consistency estimates and were moderately-to-strongly correlated with each other (internal
validity). Further, several domains were strongly, positively associated longer measures of
the same (or similar) constructs and the associations between mental health symptoms and
substance use outcomes were remarkably similar across the brief DSM-5 level 1 measure
mental health domains and the longer, more validated measures assessing these constructs
(convergent validity). Not only were the 13 domain measures negatively associated with
self-esteem, but they tended to correlate strongly with other theoretically-relevant constructs
such as posttraumatic stress (criterion-related validity). Taken together, our findings further
support the utility of this measure in non-clinical samples (Hurst & Kavanagh, 2017).

Author Manuscript

Specific to the present study, our findings provide evidence that the DSM-5 level 1 measure
could have incredible value as a brief, comprehensive measure of mental health among
college students. Given its brevity, we anticipate that a growing number of researchers will
strategically use the DSM-5 level 1 measure in college student populations. As the first
study using this measure in this population, we have provided detailed information about
prevalence rates in our total sample and both site-specific and racial/ethnic subsamples to
facilitate comparisons in future studies. Although the present study relied on convenience
sampling, which limits our contributions from an epidemiological perspective, we provide a
strong reference point to which other studies using the DSM-5 level 1 measure can be
compared. Moreover, and with particular attention to the high rates of substance use among
college students, brief motivational interventions may also benefit from using the DSM-5
level 1 measure to gain a fuller picture of the mental health issues associated with college
student substance use. In fact, incorporating the DSM-5 level 1 measure into such
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interventions can help guide conversations surrounding the facilitative and detrimental
effects of substance use.
Limitations and Future Directions

Author Manuscript

Despite the importance of these findings, our study was not without its limitations. The
cross-sectional study design prevents the examination and demonstration of temporal
precedence. Furthermore, the present study did not collect clinical diagnosis data to
determine if the proposed cutoffs by Narrow and colleagues (2013) are valid for the college
population. Additional work is needed to examine the sensitivity and specificity of the
DSM-5 level 1 to inform its utility as a mental health screener among college students.
Moreover, further validation of the DSM-5 level 1 measure will increase confidence in
current findings, as well as facilitate epidemiological research on the prevalence, incidence,
and impact of psychopathology among college students and aid in developing profiles for atrisk student.

Author Manuscript

Although we had multiple mental health measures resulting in our ability to compare the
DSM-5 level 1 measure estimates of specific psychopathology to more comprehensive
measures of overlapping constructs, we did not compare the measure to larger,
comprehensive measures of overall psychopathology (e.g., Counseling Center Assessment
of Psychological Symptoms-62; Locke et al., 2011). These comparisons are needed to
determine whether researchers can use the measure to evaluate the myriad of psychiatric
issues commonly experienced by college students without placing undue burden on them
through extensive psychological evaluation. Finally, the DSM-5 Level 1 measure currently
does not have normative data and has not been evaluated according to the Standards for
Educational and Psychological Testing which is needed to provide greater empirical
validation of the measure (see Al-Dajani, Gralnick, & Bagby, 2015 for an example of testing
a DSM-5 measure using these standards).
Conclusions

Author Manuscript

The current study provides psychometric validation of the DSM-5 Self-Rated Level 1 CrossCutting Symptoms Measure with a large, diverse sample of non-treatment-seeking college
students. The high prevalence of hazardous substance use and increasing rates of mental
health issues among college students points to the DSM-5 level 1 measure as a viable tool to
identify and address the needs of this population. Further, the tool may prove useful for
empirical investigations of the profiles of at-risk students while minimizing relative
participant burden. Although additional validation of the DSM-5 level 1 measure with the
college student population is needed, we foresee opportunities to augment epidemiological
research, theoretical conceptualizations, and clinical applications using the DSM-5 level 1
measure with the college student population.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Note. DASS=Depression Anxiety Stress Scales; FNE=Fear of Negative Evaluation; PTSD=posttraumatic stress disorder; AUDIT=Alcohol Use Disorder Identification Test; CUDIT=Cannabis Use Disorders Identification Test. Ns range from 4,018 (among CUDIT associations
assessed among lifetime marijuana users), 6,366 (among AUDIT associations assessed among lifetime alcohol users), to 7,217 (total sample). Significant associations are in bold typeface for emphasis and were determined by a 99% bias-corrected standardized bootstrapped
confidence interval (based on 10,000 bootstrapped samples) that does not contain zero. Correlations among non-DSM level 1 cross-cutting symptoms domains are available upon request from the authors.
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associations assessed among past 30-day alcohol users). Gender was coded 0=male, 1=female. Significant associations are in bold typeface for emphasis and were determined by a 99% bias-corrected standardized bootstrapped confidence interval (based on 10,000 bootstrapped
samples) that does not contain zero.
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